Trial to Compare the Relative Pharmacodynamic Properties of Different Glucagon Dosages
Status:
Completed
Trial end date:
2013-11-01
Target enrollment:
Participant gender:
Summary
The ultimate goal of the PCDIAB project is to develop a bi-hormonal pump (insulin and
glucagon) substituting for the pancreas and facilitating tight euglycemic control in patients
with T1DM.